Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Texas Heart Institute designates this educational activity for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 45 minutes.
If you previously completed and received credit for the live CME-sponsored grand rounds entitled, STEMI: Adjunct Therapy & Utility of DES, on May 7, 2010, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.
Term of Approval
June 15, 2010 through June 15, 2012. Continuation of CME credit from June 15, 2012 depends on a thorough review of the content for currency and accuracy.
In May 2010, this continuing medical education activity was reviewed for currency and accuracy of content by Patrick J. Hogan, MD, FACC, Director, Learning Resource Center and Co-Chairman, Medical Education Committee—Texas Heart Institute, Houston, Texas. Dr. Hogan does not have any disclosures relevant to this program.
Disclosure of Relationships Faculty Disclosure
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, faculty members have disclosed their relationships, either with the manufacturers of commercial products discussed, or with the corporate organizations offering educational grants for the live continuing medical education activity.
Dr. Dangas plans to discuss unlabeled or investigational uses of product. Dr. Dangas is a consultant for Sanofi Aventis, Bristol-Myers Squibb, Eli Lilly, Accumetrics, Medtronic, Boston Scientific Corporation, Abott, and Cordis. He is also on the speaker's bureau of Astra Zeneca.